Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials
文献类型:期刊论文
作者 | Galling, Britta ; Roldan, Alexandra ; Rietschel, Liz ; Hagi, Katsuhiko ; Walyzada, Frozan ; Zheng, Wei ; Cao, Xiao-Lan ; Xiang, Yu-Tao ; Kane, John M. ; Correll, Christoph U. |
刊名 | EXPERT OPINION ON DRUG SAFETY
![]() |
出版日期 | 2016 |
卷号 | 15期号:5页码:591-612 |
ISSN号 | 1474-0338 |
学科主题 | Pharmacology & Pharmacy |
语种 | 英语 |
公开日期 | 2016-12-16 |
源URL | [http://ir.gibh.ac.cn/handle/344009/856] ![]() |
专题 | 广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文 |
推荐引用方式 GB/T 7714 | Galling, Britta,Roldan, Alexandra,Rietschel, Liz,et al. Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials[J]. EXPERT OPINION ON DRUG SAFETY,2016,15(5):591-612. |
APA | Galling, Britta.,Roldan, Alexandra.,Rietschel, Liz.,Hagi, Katsuhiko.,Walyzada, Frozan.,...&Correll, Christoph U..(2016).Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.EXPERT OPINION ON DRUG SAFETY,15(5),591-612. |
MLA | Galling, Britta,et al."Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials".EXPERT OPINION ON DRUG SAFETY 15.5(2016):591-612. |
入库方式: OAI收割
来源:广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。